Donepezil in Preventing Delirium in Hospitalized Elderly
Postoperative Complications, Delirium
About this trial
This is an interventional prevention trial for Postoperative Complications focused on measuring Hospital acquired complications, adverse effects, Cognitive Impairment, Aging
Eligibility Criteria
Inclusion Criteria: Community-dwelling individuals aged 65 or older Admitted to Methodist Hospital for surgical repair of hip fracture No evidence of delirium at admission to hospital MMSE total score below 24 points after adjustment for education and age Consent to participate in the study Exclusion Criteria: Severely demented as defined by MMSE score below 10 Metastatic cancer or other comorbid illnesses likely to reduce life expectancy to under 6 months Multiple trauma or pathological fractures Aphasic, legally blind, or deaf Use of Donepezil or other cholinesterase inhibitors within one month prior to surgery Allergy to Donepezil
Sites / Locations
- Methodist Hospital, Clarian Health Partners